This video shows a tricuspid valve replacement in a patient with severe endocarditis.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
March 14, 2016
The Hopkins group reviewed differential outcomes in close to 800 patients who had undergone bilateral IMA revascularization during CABG. The compared configurations included:
March 13, 2016
This Belgian study prospectively analyzed the predictors of long-term mortality in a group of 107 consecutive CABG patients with an LV EF < 35%. All patients underwent preoperative Cardiac MR to assess both LV and RV EF.
March 13, 2016
The authors reviewed the Medicare database to analyze the trends in CABG surgery within this population over a 12-year period. Trends in the Medicare population included the following:
March 11, 2016
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease. This rationale includes the following:
March 10, 2016
This video show a mitral valve repair in a 64-year-old woman with class III dyspnea and severe mitral regurgitation.
March 8, 2016
This video shows a complex robotic-assisted mitral valve repair performed for active endocarditis with persistent bacteremia, fevers, and embolic neurologic events.
March 7, 2016
This is a very interesting and provocative article that discusses Exracorporeal Cardiac Life Support (ECLS) as an adjunct to CPR. ECLS has gained in popularity with new tools and techniques, ECLS guidelines, protocols and better understanding of the importance of early initiation.
March 7, 2016
The authors report on the transplantation of allogeneic bone graft in 10 patients with massive post-sternotomy defects. There were no further complications in 6 patients. In 3 patients additional re-suture of the soft tissue was necessary and one patient died 6 months later.
March 7, 2016
The analysis compares 1478 patients who underwent CABG and received no red blood cell (RBC) transfusion to 1528 CABG patients with 1–2 units of RBCs. The 30-day mortality rate was 0.3% and 0.2%, respectively. The propensity score-adjusted odds ratio (OR) in the RBC+ group was 0.29 [95% confidence interval (CI): 0.06–1.50; P = 0.14].